-
Australian lawmaker 'critically' hurt in attack, officials say
-
'Physical hell': Hong Kong hosts gruelling underwater hockey tournament
-
Indonesia fires burned over 1.9 mn hectares through September: monitor
-
Police 'lost control' during French protests, says interior minister
-
Asian tech stocks mixed after Wall St losses, eyes on earnings
-
Australia's new Ghost Shark submarines grow some 'teeth'
-
China's third-quarter growth narrowly beats forecasts
-
'I call it a bribe': Pennsylvania residents spurn $10,000 data center checks
-
Asian stocks start week on back foot, tracking tech-led Wall St losses
-
In a former US steel city, ordinary people struggle to get by
-
China growth narrowly beats forecasts
-
'Liar,' 'clown': Lula and Bolsonaro spar in Brazil poll debate
-
Faith and fury: Texas Senate rivals offer contrasting visions
-
Record El Nino? Depends who's counting
-
Women await justice for police killings in Brazil
-
On the front line of ocean conservation off Portugal's Madeira
-
The painstaking task of cataloguing the world's species
-
Wembanyama targets title breakthrough as NBA season tips off
-
Nations seek reset at UN talks as nature goals off track
-
With LeBron on board it's title or bust for Philly fans
-
Rubio seeks to strengthen US foothold in Central Asia
-
One year after Louvre heist, where are the missing jewels?
-
LeBron joins 76ers to chase one more NBA title at age 41
-
Knicks face tall task in NBA championship repeat bid
-
Rays one win from World Series return after downing Guardians
-
Warriors' Curry 'fine' after limping out of practice - Kerr
-
BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 19
-
Caledonia Mining Corporation Plc: Notification of Relevant Change To Significant Shareholder
-
Hemogenyx Pharmaceuticals PLC Announces Feasibility Study Agreement
-
Kings' Ben Simmons tears Achilles in training
-
Zelensky speaks to US envoys as Trump lashes out
-
Lula, Bolsonaro set for first debate showdown in bitter election race
-
'Surprise package' Lazio crush Juve to keep pace with Serie A leaders Inter
-
Mbappe hits two as Real Madrid rout Sevilla
-
China growth expected to miss official target in third quarter
-
Browns edge Ravens for division lead, Texans beat Jags
-
Lazio crush Juventus to move level with Serie A leaders Inter
-
Lyon go top of Ligue 1 as Monaco fall to first defeat of the season
-
Leeds draw feels like 'fresh start' for Man Utd's Carrick
-
Venezuela opposition alliance reaffirms Nobel laureate Machado as leader
-
Macron denounces 'unbridled' violence as France hit by new clashes
-
'Street Fighter' wins N. America box office, buzzy doc stuns in 2nd
-
Hurzeler lauds 'hard worker' Gomez after Brighton goal from halfway line
-
NFL: Paris game to go ahead despite protests in France
-
Toulouse hold off Exeter, Northampton save English Champions Cup blushes
-
Arteta hails Arsenal 'finishers' after Madueke fells Forest
-
Arsenal snatch late win to keep pressure on Man City as Man Utd held
-
Trump backs ally Netanyahu ahead of Israel's tight election
-
Arsenal strike late to keep pressure on Man City as Man Utd held
Dressing 'revolution' seeks artificial skin for burn victims
Far from the humble sticking plaster, medical firms and researchers are seeking to create the "ultimate dressing" -- artificial skin they hope will revolutionise the treatment of severe burns.
For the last 18 months, researchers from the French firm Urgo have been working towards achieving this Holy Grail of wound treatment, which would save serious burn victims from the painful and repeated skin grafts they currently endure.
The 100-million-euro ($106,000-million) "Genesis" project hopes to have a product ready by 2030.
Guirec Le Lous, the president of Urgo's medical arm, told AFP that it is a "crazy" project.
"Are we capable of designing artificial skin in a laboratory? No one in the world has succeeded," he said.
Inside Urgo's laboratory in Chenove, near the eastern French city of Dijon, living cells are being chilled before they can be cultivated.
"You have to be able to recreate all the functions of skin," including protecting against external threats and regulating the temperature, Le Lous said.
It must also be relatively easy to make, because artificial skin must be "available for all and at the right price," he said, without revealing the exact technology or type of cells Urgo is using.
Urgo, a family-owned business since 1880, has long made dressings for chronic wounds such as diabetic foot ulcers and venous leg ulcers.
"Since the 2000s, we have worked on materials that will correct healing problems: dressings have become intelligent, interactive with wounds, allowing them to perform better," Urgo's research director Laurent Apert said.
He called the change "a revolution".
- Silver bullet -
Urgo is far from alone in pushing the boundaries of what dressings can do.
Researchers at the University of South Australia have developed a new kind of dressing that knows when to release nanoparticles of silver, which can break down antibiotic-resistant bacteria.
"Our treatment is unique in that it capitalises on the anti-bacterial properties of silver, but avoids over-exposure, by only activating when infection in present," lead researcher Zlatko Kopecki said in a statement.
This makes the dressing "a much safer and effective treatment for children," he added.
Children suffer almost half of burn injuries worldwide, most of them aged between one to five years old, according to research using the World Health Organization's Global Burn Registry.
- 'Night and day' -
Another new technique does away with the idea of dressing altogether.
For a product from French startup VistaCare Medical, patients put their affected leg into a large device which never touches their wound.
Instead the chamber controls the humidity, temperature and other aspects important to healing.
"There is no more dressing. The idea is to put the wound in an enclosure, in a sterile air, VistaCare Medical president Francois Dufay said.
"With this system, we provide the wound with what it needs, at the right time."
VistaCare Medical's device is currently used in around 20 French hospitals, but next year the firm plans to apply for approval in the United States for a product to be used in the home.
The new developments have shaken up the world of wound healing, long a neglected area of medical research.
Isabelle Fromantin, who heads the wounds and healing research unit at the Curie Institute in Paris, said that "compared to 20 years ago, it's night and day in terms of wound care".
Along with her team, Fromantin has developed dressings that reduce the odours from necrotic wounds seen in some cancers.
However she said that not everything can be achieved by new technologies -- healing is a process that varies from person to person, depending on their age and health.
"Believing that a dressing will heal you all by itself is utopian," she said.
O.Ortiz--AT